Inventor
David J. Calderwood
Inventor
Framingham, MA, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds41%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes14%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
Y02ATechnologies for adaptation to climate change6%
C07KPeptides2%
C12NMicroorganisms or enzymes2%
PatentTitleYear
9,365,579'Tricyclic compounds'20169,029,409'Isoxazolines as therapeutic agents'20158,962,629'Tricyclic compounds'20158,785,639'Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof'20148,551,981'Furo[3,2-d]pyrimidine compounds'20138,273,736'Thienopyridine and furopyridine kinase inhibitors'20128,188,083'Triazolopyridazines'20128,008,481'Indazole compounds'20117,863,444'4-aminopyrrolopyrimidines as kinase inhibitors'20117,829,570'Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors'20107,790,741'Imidazothiazoles and imidazoxazoles'20107,737,160'Thienopyridine and furopyridine kinase inhibitors'20107,709,468'Imidazo based heterocycles'20107,400,979'Method of identifying inhibitors of Lck'20087,332,497'Pyrazolopyrimidines as therapeutic agents'20087,202,363'Thienopyridine and furopyridine kinase inhibitors'20077,071,199'Kinase inhibitors as therapeutic agents'20067,060,822'2-pyrazolin-5-ones'20067,049,312'Benzothiazinone and benzoxazinone compounds'20066,921,763'Pyrazolopyrimidines as therapeutic agents'20056,713,474'Pyrrolopyrimidines as therapeutic agents'20046,660,744'Pyrazolopyrimidines as therapeutic agents'20036,326,500'Imidazole derivatives for blocking the release of arachidonic acid from phospholipids'20016,215,001'Imidazole derivatives as therapeutic agents'20016,031,109'Phenoxy-, phenylthio-, benzoyl-alkyleneaminoalkylene-imidazole derivatives as therapeutic agents'20006,001,839'Substituted 4-amino-7H-pyrrolo [2,3,-d]-pyrimidines as PTK inhibitors'19995,780,642'Imidazole derivatives as therapeutic agents'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2006Based in Nottingham, GB· patent location history
2001–2012Patents assigned to ABBOTT LAB (11)· patent assignee history
2003–2008Patents assigned to ABBOTT GMBH & CO KG (5)· patent assignee history
2003–2016Based in Framingham, MA, US· patent location history
2006Based in Farmingham, MA, US· patent location history
2011–2015Patents assigned to CALDERWOOD DAVID J (7)· patent assignee history
2011–2014Patents assigned to MULLEN KELLY D (5)· patent assignee history
2013–2016Patents assigned to ABBVIE INC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 11 | 2001–2012 |
| CALDERWOOD DAVID Jself | 7 | 2011–2015 |
| ABBOTT GMBH & CO KG | 5 | 2003–2008 |
| ABBVIE INC | 5 | 2013–2016 |
| MULLEN KELLY D | 5 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Framingham, Massachusetts, US | 20 | 2003–2016 |
| Nottingham, GB | 6 | 1998–2006 |
| Farmingham, Massachusetts, US | 1 | 2006 |